HARVARD BIOSCIENCE INC Quarterly Amortization of Intangible Assets in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Harvard Bioscience Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2010 to Q3 2024.
  • Harvard Bioscience Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $1.33M, a 1.98% decline year-over-year.
  • Harvard Bioscience Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $5.39M, a 6.64% decline year-over-year.
  • Harvard Bioscience Inc annual Amortization of Intangible Assets for 2023 was $5.53M, a 9.75% decline from 2022.
  • Harvard Bioscience Inc annual Amortization of Intangible Assets for 2022 was $6.12M, a 4.83% increase from 2021.
  • Harvard Bioscience Inc annual Amortization of Intangible Assets for 2021 was $5.84M, a 2.28% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.39M $1.33M -$27K -1.98% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $5.41M $1.33M -$58K -4.18% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.47M $1.33M -$55K -3.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $5.53M $1.39M -$243K -14.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $5.77M $1.36M -$211K -13.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $5.98M $1.39M -$65K -4.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.04M $1.39M -$78K -5.32% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $6.12M $1.63M +$178K +12.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $5.94M $1.57M +$113K +7.75% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $5.83M $1.45M -$11K -0.75% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $5.84M $1.47M +$2K +0.14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 $5.84M $1.45M $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $5.84M $1.46M +$82K +5.96% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.76M $1.47M +$11K +0.76% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $5.75M $1.46M +$37K +2.59% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $5.71M $1.45M -$6K -0.41% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $5.72M $1.38M -$45K -3.17% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $5.76M $1.45M +$18K +1.25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $5.74M $1.43M -$3K -0.21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $5.75M $1.46M +$57K +4.07% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-03-17
Q3 2019 $5.69M $1.42M -$46K -3.13% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $5.74M $1.44M +$24K +1.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.71M $1.43M +$327K +29.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $5.38M $1.4M +$1.01M +255% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $4.38M $1.47M +$1.07M +267% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $3.31M $1.41M +$1.03M +270% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.28M $1.1M +$727K +193% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.55M $395K -$228K -36.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $1.78M $400K -$329K -45.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $2.11M $382K -$308K -44.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $2.42M $376K -$304K -44.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $2.72M $623K -$59K -8.65% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $2.78M $729K +$63K +9.46% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $2.72M $690K +$12K +1.77% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $2.71M $680K -$113K -14.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $2.82M $682K -$57K -7.71% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $2.88M $666K +$48K +7.77% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $2.83M $678K +$91K +15.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2.74M $793K +$159K +25.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $2.58M $739K +$104K +16.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-17
Q3 2014 $2.47M $618K +$18K +3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $2.46M $587K -$89K -13.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $2.55M $634K -$45K -6.63% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $2.59M $635K -$46K -6.76% Oct 1, 2013 Dec 31, 2013 10-K 2016-04-29
Q3 2013 $2.64M $600K -$81K -11.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $2.72M $676K -$36K -5.06% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $2.75M $679K +$1K +0.15% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $2.75M $681K -$49K -6.71% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $2.8M $681K -$25K -3.54% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $2.83M $712K +$23K +3.34% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $2.8M $678K +$57K +9.18% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $2.75M $730K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-14
Q3 2011 $706K +$113K +19.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $689K +$111K +19.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $621K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $593K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $578K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.